Lipoprotein(a) and Risk of Treated Ventricular Arrhythmias in Heart Failure - Top-Institutions - MDSpire

Lipoprotein(a) and Risk of Treated Ventricular Arrhythmias in Heart Failure

  • By

  • Ramzi Ibrahim

  • Luke Dreher

  • Hussein Abdul Nabi

  • Juan Maria Farina

  • Eiad Habib

  • Hoang Nhat Pham

  • Min Choon Tan

  • Hussein A. Noureldine

  • Sammudeen Ibrahim

  • Mayurkumar Bhakta

  • Kwan Lee

  • Dan Sorajja

  • Win-Kuang Shen

  • Luis R. Scott

  • Chadi Ayoub

  • Reza Arsanjani

  • Hicham Z. El Masry

  • May 26, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Cardiology

  • #2

    Centre Hospitalier Universitaire Limoges
    Centre Hospitalier Universitaire Limoges

    Limoges, Nouvelle-Aquitaine

    Key Differentiators

    • Cardiology

Original Source(s)

Lipoprotein(a) and Risk of Treated Ventricular Arrhythmias in Heart Failure

  • by Ramzi Ibrahim, Luke Dreher, Hussein Abdul Nabi, Juan Maria Farina, Eiad Habib, Hoang Nhat Pham, Min Choon Tan, Hussein A. Noureldine, Sammudeen Ibrahim, Mayurkumar Bhakta, Kwan Lee, Dan Sorajja, Win-Kuang Shen, Luis R. Scott, Chadi Ayoub, Reza Arsanjani, Hicham Z. El Masry

  • May 26, 2026

Related Content

Impact of Previous Cardiac Surgery on Outcomes After Tricuspid Valve Transcatheter Edge-to-Edge Repair: Insights from EuroTR

Molecular and cellular adaptations to extended hypothermic oxygenated perfusion in donation-after-circulatory-death hearts in a porcine model

Corvad as a bridge to LVAD implantation in end-stage heart disease complicated by cardiogenic shock: a three-case series